These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model. Oguz H; Ozbilge H; Oguz E; Gurkan T Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740 [TBL] [Abstract][Full Text] [Related]
3. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit. Dajcs JJ; Hume EB; Moreau JM; Caballero AR; Cannon BM; O'Callaghan RJ Invest Ophthalmol Vis Sci; 2000 May; 41(6):1432-7. PubMed ID: 10798659 [TBL] [Abstract][Full Text] [Related]
4. Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis. Callegan MC; Hobden JA; Hill JM; Insler MS; O'Callaghan RJ Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3017-23. PubMed ID: 1399405 [TBL] [Abstract][Full Text] [Related]
5. Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis. Callegan MC; Engel LS; Hill JM; O'Callaghan RJ Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1033-7. PubMed ID: 8125714 [TBL] [Abstract][Full Text] [Related]
6. Keratotomy model of pseudomonas keratitis: gentamicin chemotherapy. Brockman EB; Tarantino PA; Hobden JA; Hill JM; O'Callaghan RJ; Kaufman HE; Insler MS Refract Corneal Surg; 1992; 8(1):39-43. PubMed ID: 1554638 [TBL] [Abstract][Full Text] [Related]
7. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa. Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131 [TBL] [Abstract][Full Text] [Related]
8. Ocular virulence of capsule-deficient streptococcus pneumoniae in a rabbit keratitis model. Reed JM; O'Callaghan RJ; Girgis DO; McCormick CC; Caballero AR; Marquart ME Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):604-8. PubMed ID: 15671288 [TBL] [Abstract][Full Text] [Related]
17. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae. Knudsen JD Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659 [TBL] [Abstract][Full Text] [Related]
18. The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar (gatifloxacin 0.3%) in a NZW rabbit model. Romanowski EG; Mah FS; Yates KA; Kowalski RP; Gordon YJ Am J Ophthalmol; 2005 May; 139(5):867-77. PubMed ID: 15860293 [TBL] [Abstract][Full Text] [Related]
19. Staphylococcus corneal virulence in a new topical model of infection. Hume EB; Dajcs JJ; Moreau JM; Sloop GD; Willcox MD; O'Callaghan RJ Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2904-8. PubMed ID: 11687535 [TBL] [Abstract][Full Text] [Related]
20. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus keratitis in rabbits. Tas T; Kucukbayrak A; Hakyemez IN; Mengeloglu FZ; Simavli H; Ozyalvacli G; Erdurmus M Cornea; 2013 Jul; 32(7):1052-7. PubMed ID: 23665649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]